BridgeMD
New treatment option for Coronary Artery Disease
Official title Personalized Activity Intervention in Rehabilitation After Cardiac Operations (the PACO Trial)
ClinicalTrials.gov ID: NCT03470246
What this study is testing
- What it's testing
- The PACO trial is a randomized clinical trial conducted in Heart Centers of Kuopio and Turku university hospitals. The coronary artery disease, aortic valve stenosis and mitral valve insufficiency patients preparing for elective coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or mitral valve repair (MVR) will be randomized to either intervention or control group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 90
You may be able to join if
- An eligible patient with coronary artery disease, aortic valve stenosis or mitral valve insufficiency scheduled for elective coronary artery bypass...
- He / she does not have any severe disease or functional limitation limiting PA (other than CVD).
- He / she is willing to wear a hip- and wrist-worn accelerometer.
- He / she is willing and capable to use a smart phone application.
You likely can't join if
- He / she ends up in prolonged intensive care after cardiac operation.
- He / she has a memory disorder (i.e. Alzheimer's disease).
The study team makes the final eligibility decision.
Where it's taking place
- Kuopio, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kuopio, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.